School of Medicine
Showing 1-100 of 256 Results
-
Vyas Akondi, PhD
Senior Research Scientist - Basic Life, Ophthalmology
Current Role at StanfordMy role is to advance the development of next-generation clinically relevant adaptive optics ocular imaging devices to allow early disease diagnosis and monitoring through a non-invasive visualization of subcellular structures in the eye.
-
Deborah Alcorn, MD
Associate Professor of Ophthalmology at the Stanford University Medical Center, Emerita
Current Research and Scholarly InterestsGene linkage - tuberous sclerosis; stabismus and, molteno implants; congenital stationary night blindness
-
Jill Beyer, OD
Clinical Assistant Professor, Ophthalmology
BioJill Beyer, OD, is a Clinical Assistant Professor at Stanford University School of Medicine.
Dr. Beyer graduated from Southern California College of Optometry, earning her Doctor of Optometry degree with distinction. She completed her residency at New England College of Optometry in Boston, Massachusetts, and earned a Bachelor of Science degree in Biology from Oregon State University.
Jill’s residency education included time spent at the Boston Foundation for Sight, Massachusetts Eye and Ear Infirmary, Cornea Consultants & Boston Laser Center, and Harvard Vanguard Medical Associates.
After residency training, Jill continued on as a clinical preceptor at the New England College of Optometry while working in private practice in Boston. She then transitioned to full time academic work at the Massachusetts Eye and Ear Infirmary becoming the Director of the Contact Lens Department and an Instructor in Ophthalmology at Harvard Medical School. -
Mark S. Blumenkranz, MD, MMS
H. J. Smead Professor of Ophthalmology, Emeritus
Current Research and Scholarly InterestsClinical Interest and Research
My primary areas of interest are in the diagnosis, medical and surgical treatment of vitreal retinal diseases. These principally include age-related macular degeneration and other diseases of the macula, and tractional syndromes, diabetic retinopathy, and complex forms of retinal detachment. I have been interested in the development of novel technology to diagnose and treat these diseases, including new forms of imaging, laser delivery systems, other microsurgical tools, and new drugs and drug delivery systems that inhibit new blood vessel growth, scarring and intraocular inflammation. I have been actively involved in translational research in the laboratory as well as technology transfer associated with that research for a variety of new therapies that have received FDA clearance and been introduced into clinical practice over the past 30 years.
Administrative and Community Service
I have served on the Board of Directors of a variety of voluntary education and service organizations, including the Corporation of Brown University, multiple scientific advisory boards and various philanthropic and research organizations. -
Evan G. Cameron
Instructor, Ophthalmology
Current Research and Scholarly InterestsMy longstanding research interest is to understand the cellular, molecular, and transcriptional mechanisms that underlie pathological vision loss. Currently, my work focuses on the contributions of reactive astrocytes in retinal ganglion cell degeneration in glaucoma with the goal of developing novel “gliotherapeutics” to promote neuroprotection, regeneration, and functional recovery.
-
Robert Chang, MD
Associate Professor of Ophthalmology
On Leave from 01/17/2022 To 01/30/2022Current Research and Scholarly InterestsI'm interested in digital health, commercialization of new technology, and the biodesign education process. I have expertise in mobile health and clinical validation of new eye care devices.
-
Fang Chen (Rosy)
Postdoctoral Scholar, Ophthalmology
Current Research and Scholarly InterestsCorneal regeneration via hydrogel-based cell scaffold and cell encapsulation
-
Wei Chen
Postdoctoral Scholar, Ophthalmology
BioMy long-term goals involve the development of a full understanding of key molecular mechanisms and the identification of corresponding therapeutics for human diseases. My research training and academic experience have provided me with an excellent background necessary in multiple fields including molecular biology, cell biology, medicinal chemistry, and biochemical pharmacology. We first revealed a novel mechanism underscoring the regulation of metabolic profiles and mitochondrial function of epithelial cells by IL-22 during cell injury, which might provide useful insights from the bench to the clinic in treating and preventing more diseases, especially acute stroke/traumatic brain injuries. We subsequently demonstrated that autophagy was induced to play cytoprotective roles in numerous cells, which highlighted the potential therapeutic strategies for CNS neurodegeneration diseases or cancer by targeting autophagy. For my postdoctoral training, I continue to build on my previous researches in metabolic profiles and mitochondrial function regulations by concentrating on determining the role of mitochondrial thioredoxin metabolism in neuronal survival.
-
E.J. Chichilnisky
John R. Adler Professor, Professor of Neurosurgery and of Ophthalmology and, by courtesy, of Electrical Engineering
On Partial Leave from 01/01/2022 To 03/31/2022Current Research and Scholarly InterestsFunctional circuitry of the retina and design of retinal prostheses
-
Diana Do, MD
Professor of Ophthalmology
Current Research and Scholarly InterestsDr. Do's research focuses on collaborative clinical trials to investigate novel treatments for retinal vascular diseases and ocular inflammation. She performs research to develop state of the art therapies for age-related macular degeneration, diabetic eye disease, retinal vein occlusion, retinal inflammation, and retinal detachment.
-
Doan Luong Hien
Affiliate, Ophthalmology
BioDr. Doan Luong Hien is a vitreoretinal and uveitis specialist at the Ho Chi Minh Eye Hospital in Saigon, Vietnam.
From a young age, Dr. Hien knew that he wanted to serve others through medicine. His parents inspired him to continue the family tradition of pursuing a career in ophthalmology, as Dr. Hien comes from a long line of healthcare professionals. Dr. Hien’s grandmother is a physician, his brother is a medical student in the United States, and his aunt was the Vice Chief of the department of vitreoretinal surgery at the Ho Chi Minh Eye Hospital. As a high school student, Dr. Hien spent a considerable amount of time volunteering in eye clinics and growing his passion for ophthalmology.
He graduated from the Pham Ngoc Thach Medical University in 2013 and was one of only a few graduates to qualify and pass the doctors’ auditions for hospital in-patient management. After performing in the top percentile of ophthalmology residency exam, Dr. Hien was appointed to work at the Ho Chi Minh Eye Hospital by the Ho Chi Minh Ministry of Health in 2013. Dr. Hien completed is residency training in 2017. A few years later, Dr. Hien accepted a position for a vitreoretinal and uveitis fellowship at the Byers Eye Institute at Stanford University School of Medicine with Dr. Quan Dong Nguyen.
Dr. Hien is the recipient of numerous awards and accolades. He has also presented a number of peer-reviewed presentations and publications.
PRESENTATIONS
“Rhabdomyosarcoma in children”
At Vietnam Pediatric ophthalmology conference Da Nang, Viet Nam 16-17 May 2015
“How to effectively manage patient information with Excel”
At Vietnam Ophthalmology Society Can Tho, Viet Nam 20-22 October 2016
“Treatment outcomes of idiopathic epiretinal membranes classified by morphologic differences on optical coherence tomography”
At Science and Technique Congress, Pham Ngoc Thach university, Ho Chi Minh city, Viet Nam, 3 May 2017
“Myopic traction maculopathy”
At the 7th Vietnam Vitreo-retina club meeting Phu Quoc, Viet Nam 29 July 2017
“Approach posterior uveitis”
At the 8th Vietnam Vitreo-retina club meeting Vinh, Viet Nam 6-7 July 2018
“Case report Optic disc pit”
At the 12th Asia-Pacific Vitreo-retina Society 14-16 December 2018 Seoul, Korea
PUBLICATION
-Retinal arterial occlusive vasculitis following intravitreal brolucizumab administration.
-Yet Another Case of Ocular Sarcoidosis
-Efficacy and Safety of Intravitreal Anti-VEGF Therapy in Diabetic Retinopathy: What We Have Learned and What Should We Learn Further
-Impending Central Retinal Vein Occlusion in Patient with Idiopathic Cutaneous Leukocytoclastic Vasculitis
-Anti-interleukin-6 Receptor Therapy with Tocilizumab for Refractory Pseudophakic Cystoid Macular
-Reperfusion of Retinal Ischemia in Retinal Occlusive Vasculitis with Nicotinic Acid and Infliximab in Adamantiades-Behçet’s Disease
AWARD
-First prize vitreo-retina surgery video contest. “ Surgery for optic disc pit ”
At the 7th Vietnam Vitreo-retina club meeting Phu Quoc, Viet Nam 29 July 2017
-First prize surgery technique video contest “ IOL rescues using Yamane technique”
At Vietnam Ophthalmology Society Can Tho, Viet Nam 20-22 October 2016
-First prize surgery technique video contest “ IOL rescues using Yamane technique”
At Vietnam Ophthalmology Society Ho Chi Minh, Viet Nam 8-11 November 2018
MEDICAL RESEARCH
“Surgical management of giant retina tear with vitrectomy using different postoperative internal tamponade agents”
“Evaluate treatment outcomes of idiopathic epiretinal membranes classified by morphologic differences on optical coherence tomography” -
Alfredo Dubra, PhD
Associate Professor of Ophthalmology
Current Research and Scholarly InterestsOur lab seeks to help the early diagnosing and monitoring progression of ocular, vascular, neurodegenerative and systemic diseases through novel non-invasive optical ophthalmic imaging. We pursue this goal through a multidisciplinary approach that integrates optics, computer science, vision science, electrical engineering and other engineering disciplines.
-
Peter R. Egbert, MD
Professor of Ophthalmology, Emeritus
Current Research and Scholarly InterestsOcular pathology of shaken baby syndrome
-
Benjamin Erickson, MD, MHS
Clinical Assistant Professor, Ophthalmology
Current Research and Scholarly InterestsSurgical instrument & medical device design
Reconstructive techniques & outcomes
Orbital tumors & trauma
Instruments in production:
- Erickson-Lee Pigtail Cannula (E2517, E2517), Bausch & Lomb/Storz
- Erickson-Lee Ptosis Clamp (E2515), Bausch & Lomb/Storz -
Ann Caroline Fisher, MD
Clinical Associate Professor, Ophthalmology
BioCaroline Fisher, MD, is a Clinical Associate Professor of Ophthalmology at Stanford University Hospital and Clinics. She specializes in cataract and glaucoma surgery, including minimally invasive glaucoma surgery.
She completed her undergraduate education at Stanford University, obtaining both a Bachelor of Science degree in Biology and a Bachelor of Arts degree in Spanish, with Departmental Honors. She earned her medical degree from Stanford University School of Medicine and then went on to her internship at the University of Pennsylvania Presbyterian Hospital. She completed her ophthalmology residency at NYU/ Manhattan Eye, Ear, Throat Hospital. She then returned to Stanford for her Glaucoma Fellowship.
Dr. Fisher is Director of the Stanford Belize Vision Clinic, dedicated to promoting eye health and care in Belize, and providing an international rotation for Stanford Ophthalmology Residents. She is also an Office of Faculty Development and Diversity Liaison and is currently one of the Stanford Network for Advancement and Promotion (SNAP) Cohort Leaders. Dr. Fisher is the Director of Diversity, Equity, and Inclusion for the Department of Ophthalmology. -
Michael W. Gaynon, MD
Clinical Professor, Ophthalmology
Current Research and Scholarly Interests-Retinal Vascular Disease
-Angiogenesis
-Retinopathy of Prematurity
-Sustained Release Drug Delivery Systems -
Jeffrey Goldberg, MD, PhD
Blumenkranz Smead Professor
Current Research and Scholarly InterestsLab research on molecular mechanisms of survival and regeneration in the visual system; retinal development and stem cell biology; nanoparticles and tissue engineering. Clinical trials in imaging, biomarker development, and neuroprotection and vision restoration in glaucoma and other neurodegenerative diseases.
-
Yang Hu, MD, PhD
Associate Professor of Ophthalmology
Current Research and Scholarly InterestsThe ultimate goal of the laboratory is to develop efficient therapeutic strategies to achieve CNS neural repair, through promoting neuroprotection, axon regeneration and functional recovery.
More specifically, we study retinal ganglion cell (RGC) and optic nerve in various optic neuropathies including traumatic, glaucomatous and inflammatory optic nerve injuries to fully understand the molecular mechanisms of CNS neurodegeneration and axon regeneration failure. -
Joel Imventarza
Postdoctoral Scholar, Ophthalmology
BioDr. Imventarza is an M.D. from Argentina and a scientist who is dedicated to making basic discoveries and improving vision care and treatment of patients. Dr. Imventarza received his M.D. degree from CEMIC University in Buenos Aires, Argentina.
Shortly after, he initiated his ophthalmology residency at Escobar Eye Clinic. After completing residency, Imventarza completed the Argentine Society of Ophthalmology board examination, becoming a specialized ophthalmologist. He is trained in clinical consultations and surgical practices. He was an instructor for resident physicians and ophthalmic physicians in the clinical and surgical field.
Dr. Imventarza joined Dr. Liao's lab in May 2021 to learn new research techniques and to conduct rigorous scientific research in order to improve designing feasible experiments that are relevant to human disease.
The major areas of research is the understanding and treatment of human conditions that lead to retinal ganglion cell loss and irreversible thinning of the optic nerve.
Dr. Imventarza uses animal model to study what happens to the optic nerve, retina, and brain. -
Michael S. Kapiloff, MD, PhD
Reinhard Family Professor, Professor (Research) of Ophthalmology and, by courtesy, of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Michael S. Kapiloff is a faculty member in the Departments of Ophthalmology and Medicine (Cardiovascular Medicine) and a member of the Stanford Cardiovascular Institute. Although Dr. Kapiloff was at one time a Board-Certified General Pediatrician, he is currently involved in full-time basic science and translational research. His laboratory studies the basic molecular mechanisms underlying the response of the retinal ganglion cell and cardiac myocyte to disease. The longstanding interest of his laboratory is the role in intracellular signal transduction of multimolecular complexes organized by scaffold proteins. Recently, his lab has also been involved in the translation of these concepts into new therapies, including the development of new AAV gene therapy biologics for the prevention and treatment of heart failure and for neuroprotection in the eye.
URL to NCBI listing of all published works:
http://www.ncbi.nlm.nih.gov/sites/myncbi/michael.kapiloff.1/bibliography/40252285/public/?sort=date&direction=descending
For more information see Dr. Kapiloff's lab website: http://med.stanford.edu/kapilofflab.html -
Khizer Khaderi MD, MPH
Clinical Associate Professor, Ophthalmology
BioDr. Khizer Khaderi is Clinical Associate Professor at the Byers Eye Institute at Stanford University. Khaderi is the Director/Founder of the Stanford Human Perception Laboratory (HPL) and the Stanford Vision Performance Center (VPC), and faculty at the Stanford Institute for Human-Centered AI.
Khaderi is a renowned Neuro-Ophthalmic surgeon, technologist and futurist. He founded Vizzario Inc, a perceptual AI company, spun out from HPL. Khaderi has extensive domain expertise in artificial intelligence (AI), virtual reality (VR), augmented reality (AR), mixed reality (MxR), wearables, applied neuroscience, human factors, and human-machine interfaces/interaction. His research interests include developing personalized human intelligent systems for the metaverse based on the human brain and sensory systems, developing technologies to optimize human performance, and combining biological and computational principles to expand our capabilities in research, clinical practice, and everyday life. Dr. Khaderi's approach to advance research interests and develop practical applications for everyday use is building collaborative partnerships across academia and industry.
Dr. Khaderi’s experience across industry sectors include consumer electronics, gaming, retail, life science, sports/Esports health care, Pharma, e-commerce, to name a few. He has developed novel technologies in these areas, and generated multiple invention patents. Selected as a “40 under 40”, he contributed to President Obama’s Council of Advisors on Science and Technology regarding vision technology and the aging population. He also advises multiple companies, venture firms and organizations including the Global Esports Federation, Magic Leap, Riot Games, Intel, Activision, Unity, Epic Games, Google, FB, Microsoft, Apple, NBA, Aerie Pharma, the World Health Organization, and the World Bank. -
Euna Koo, MD
Clinical Assistant Professor, Ophthalmology
BioDr. Koo is an ophthalmologist specializing in pediatric ophthalmology, retinopathy of prematurity (ROP) and adult strabismus. She received her ophthalmology training at UC San Francisco and then her fellowship training in pediatric ophthalmology and adult strabismus at Boston Children's Hospital affiliated with Harvard Medical School. She has been board certified by the American Board of Ophthalmology since 2016. Her practice reflects her clinical interests in pediatric ophthalmology (strabismus, amblyopia, pediatric cataracts, and ROP) and in adult strabismus.
She utilizes Botox in management of adult and pediatric strabismus. She also uses hidden adjustable sutures in children and adults to optimize alignment of eyes with surgery. Muscles can be adjusted up to 7-10 days after surgery.
She also has an interest in teaching medical students and residents and improving surgical training.
